{"id":"terodiline","rwe":[],"tags":[{"label":"terodiline","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Potassium voltage-gated channel subfamily H member 2","category":"target"},{"label":"KCNH2","category":"gene"},{"label":"G04BD05","category":"atc"},{"label":"Active","category":"status"},{"label":"Urinary incontinence","category":"indication"},{"label":"Calcium Channel Blockers","category":"pharmacology"},{"label":"Calcium-Regulating Hormones and Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Membrane Transport Modulators","category":"pharmacology"},{"label":"Parasympatholytics","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=TERODILINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:06:59.721119+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:07:06.629723+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TERODILINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:07:07.505145+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL363295/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:07:07.979357+00:00"}},"allNames":"dl-terodiline","offLabel":[],"synonyms":["terodiline","dl-Terodiline","terodiline hydrochloride","terodiline HCl"],"timeline":[],"approvals":[],"brandName":"Dl-Terodiline","ecosystem":[{"indication":"Urinary incontinence","otherDrugs":[{"name":"flavoxate","slug":"flavoxate","company":""},{"name":"methanthelinium","slug":"methanthelinium","company":"Shire"}],"globalPrevalence":null}],"mechanism":{"target":"Potassium voltage-gated channel subfamily H member 2","targets":[{"gene":"KCNH2","source":"DrugCentral","target":"Potassium voltage-gated channel subfamily H member 2","protein":"Potassium voltage-gated channel subfamily H member 2"}],"modality":"Small Molecule","drugClass":"terodiline","explanation":"","oneSentence":"","technicalDetail":"Terodiline acts as a selective blocker of the Kv11.1 potassium channel, specifically targeting the HCN1 subunit, which is involved in the regulation of bladder smooth muscle tone."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2603","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TERODILINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:50:58.249148","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:07:09.867280+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"flavoxate","drugSlug":"flavoxate","fdaApproval":"1970-01-15","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"oxybutynin","drugSlug":"oxybutynin","fdaApproval":"1975-07-16","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"tolterodine","drugSlug":"tolterodine","fdaApproval":"1998-03-25","genericCount":15,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"solifenacin","drugSlug":"solifenacin","fdaApproval":"2004-11-19","patentExpiry":"May 18, 2031","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"trospium","drugSlug":"trospium","fdaApproval":"2004-05-28","genericCount":11,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"darifenacin","drugSlug":"darifenacin","fdaApproval":"2004-12-22","genericCount":9,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fesoterodine","drugSlug":"fesoterodine","fdaApproval":"2008-10-31","patentExpiry":"Jun 7, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"mirabegron","drugSlug":"mirabegron","fdaApproval":"2012-06-28","patentExpiry":"Sep 30, 2036","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"terodiline","indications":{"approved":[{"name":"Urinary incontinence","source":"DrugCentral","snomedId":165232002,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"flavoxate","brandName":"flavoxate","genericName":"flavoxate","approvalYear":"1970","relationship":"same-class"},{"drugId":"oxybutynin","brandName":"oxybutynin","genericName":"oxybutynin","approvalYear":"1975","relationship":"same-class"},{"drugId":"tolterodine","brandName":"tolterodine","genericName":"tolterodine","approvalYear":"1998","relationship":"same-class"},{"drugId":"solifenacin","brandName":"solifenacin","genericName":"solifenacin","approvalYear":"2004","relationship":"same-class"},{"drugId":"trospium","brandName":"trospium","genericName":"trospium","approvalYear":"2004","relationship":"same-class"},{"drugId":"darifenacin","brandName":"darifenacin","genericName":"darifenacin","approvalYear":"2004","relationship":"same-class"},{"drugId":"fesoterodine","brandName":"fesoterodine","genericName":"fesoterodine","approvalYear":"2008","relationship":"same-class"},{"drugId":"mirabegron","brandName":"mirabegron","genericName":"mirabegron","approvalYear":"2012","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"004054","UNII":"70KG06964W","CHEBI":"CHEBI:135168","INN_ID":"2077","RXNORM":"235839","UMLSCUI":"C0076126","chemblId":"CHEMBL363295","ChEMBL_ID":"CHEMBL363295","KEGG_DRUG":"D01873","DRUGBANK_ID":"DB13725","PUBCHEM_CID":"23480","SNOMEDCT_US":"417479000","SECONDARY_CAS_RN":"7082-21-5","MESH_SUPPLEMENTAL_RECORD_UI":"C010637"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"56.0 hours","clearance":"1.1 mL/min/kg","bioavailability":"82%","fractionUnbound":"0.08%","volumeOfDistribution":"5.1 L/kg"},"publicationCount":177,"therapeuticAreas":["Urology"],"atcClassification":{"source":"DrugCentral","atcCode":"G04BD05","allCodes":["G04BD05"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1986","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:07:09.867280+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}